This study sought to directly investigate how variation in Cacna1c dosage impacts the HPA axis using a heterozygous Cacna1c rat model that reflects the reduced hippocampal CACNA1C expression associated with psychiatric disease. The gene discussed is CACNA1C; the disease is psychiatric disorder.